BioSpace News Archive

Pulse Biosciences, Inc. today announced the appointment of Laureen DeBuono to its Board of Directors.

Twist Bioscience Corporation today announced an expansion of its expert-led Alliance Panel product offering.

Tesis Labs, a leader in targeted genetic sequencing, announced $20 million of growth equity financing at a post-money valuation of $520 million.

The Boston Athletic Association (B.A.A.) and Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that Quest will be the exclusive provider of onsite COVID-19 testing for the 125th Boston marathon, to be held Monday, October 11.

Zymeworks Inc. and ALX Oncology Holdings Inc. today announced the first patient has been dosed in an open-label, multi-center Phase 1b/2 clinical trial conducted by Zymeworks.

Researchers at Vanderbilt University Medical Center are leading a study designed to identify early drivers of pulmonary fibrosis in an at-risk patient population.

Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced that members of the Aruvant leadership team will participate in the annual Cell & Gene Meeting on the Mesa which is taking place in person in Carlsbad, CA and online from October 12 to October 14, 2021

Genentech, a member of the Roche Group, announced that new Ocrevus® and EnspryngTM data will be presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis from October 13 – 15, 2021.

Oxurion NV, a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, announces its management will present at the Lytham Partners Fall 2021 Investor Conference.

Clinical stage drug development company Pharmaxis Ltd announced further positive results of data analysis from a phase 1c clinical trial studying its drug PXS-5505 in patients with the bone marrow cancer myelofibrosis for 28 days at three dosage levels.